Goa Food And Drug Administration

• 

  Goa To Start Using Drug Shunned By US Regulator For Covid Treatment

  Goa has given the nod for the use of an anti-parasitic drug as preventive treatment for all adults against COVID-19. The drug, Ivermectin, has been disapproved of by the US Food and Drug Administration (FDA).

• 

  Cipla Shares Fall 6% After US Regulator's Warning Letter On Goa Facility

  Cipla Share Price: Cipla said it will work closely with the US Food and Drug Administration (FDA) to comprehensively address all the observations.

• 

  Controversy Over Formalin In Fish Threatens Split In Goa Forward Party

  A controversy surrounding the use of formalin to preserve fish sold in Goa is threatening a split in the Goa Forward, a ruling party, even as its Vice President has accused his leadership of being mum on the issue and being a party to the victimization of a whistle-blower who exposed the formalin-in-fish scandal.

• 

  Had To Intervene As Goans Stopped Eating Fish, Says Manohar Parrikar

  Goa Chief Minister Manohar Parrikar on Sunday said he had to intervene in the ongoing controversy over the use of formalin in preserving fish, because people in the coastal state have stopped eating fish.

• 

  Will Ban Fish Import If Impurities Are Found: Goa Minister

  Goa will not mind banning the import of fish if impurities are found in it, state Food and Drugs Administration Vishwajit Rane said today.

• 

  Permissible Potassium Bromate Found In 4 Bread Samples: Goa's Food and Drugs Administration

  Goa's Food and Drugs Administration (FDA) today said four of the 18 bread samples collected in the state tested positive for potassium bromate, but within permissible limits.

• 

  Lupin Leads Selloff in Pharma Shares, Hits 52-Week Low

  Lupin shares have been reeling under selling pressure following adverse observations about the company's Goa plant by the US Food and Drug Administration earlier this week.

• 

  Lupin Receives 9 Observations From US Regulator for Goa Plant

  Drug major Lupin on Tuesday said it has received nine observations relating to inadequacy and adherence to operating norms for its manufacturing plant in Goa from the US Food and Drug Administration (FDA).

• 

  Maggi Noodles Deemed Safe for First Time Since Ban Was Ordered

  For the first time since the hugely popular snack was banned across India, Maggi Noodles has passed a test which establishes it complies with food safety standards.

• 

  Maggi Noodles Samples Found Safe by Government Lab

  In a major boost to Nestle India, FSSAI-approved laboratory of Central Food Technological Research Institute (CFTRI) has found Maggi noodles to be in compliance with the country's food safety standards.

• 

  After Banning Maggi, Goa to Destroy Its Stocks

  After banning sale of Maggi noodles in the State, the Goa Government has decided to destroy four tonnes of the instant food product which is being recalled from markets.

• 

  Now, Goa Bans Sale of Maggi Noodles

  Goa today joined several other states in banning the sale of Nestle's instant noodle brand 'Maggi' which is at the centre of a raging nationwide row over food safety concerns.

• 

  Maggi Controversy: Delhi Summons Nestle Officials, Kerala Bans it from State-Run Outlets as Tested Samples Prove Unsafe

  Kerala has ordered a pullout of Maggi noodles from government-run outlets and the Delhi government has said samples that it tested were found "unsafe," amid a country-wide scrutiny of the product for high content of lead and mono-sodium glutamate or MSG, a taste enhancer.

• Indoco Remedies Gets Approval From US Drug Regulator for Goa Facilities

  Pharma player Indoco Remedies on Monday said it has received a nod from the US Food and Drug Administration (FDA) for two of its facilities in Goa.